factor

(redirected from antihemophilic factor)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia.
Related to antihemophilic factor: Christmas factor, fibrin stabilizing factor

Factor

A financial institution that buys a firm's accounts receivable and collects the accounts.

Factor

A third party that buys a firm's accounts receivable. If a firm is not confident in its ability to collect on its credit sales, it may sell the right to receive payment to the factor at a discount. The factor then assumes the credit risk associated with the accounts receivable. This provides the firm immediate access to working capital, which is important, especially if the firm has a cash flow problem. The price of factoring is determined by the creditworthiness of the firm's customer, not of the firm itself. It is also known as accounts receivable financing.

factor

A firm that purchases accounts receivable from another firm at a discount. The purchasing firm then attempts to collect the receivables.

factor

To sell accounts receivable to another party at a discount from face value. Thus, a firm in need of cash to pay down short-term debt may decide to factor its accounts receivable to another firm.

factor

  1. a firm that purchases TRADE DEBTS from client firms. See FACTORING.
  2. a firm that buys in bulk and performs a WHOLESALING function.
  3. an input (for example raw material, labour, capital) which is used to produce a good or provide a service.

factor

  1. 1a FACTOR INPUT that is used in production (see NATURAL RESOURCES, LABOUR, CAPITAL).
  2. a business that buys in bulk and performs a WHOLESALING function.
  3. a business that buys trade debts from client firms (at some agreed price below the nominal value of the debts) and then arranges to recover them for itself. See FACTOR MARKET, FACTORING.
References in periodicals archive ?
M2 EQUITYBITES-May 12, 2014-Bayer receives approval from US FDA for Kogenate FS antihemophilic factor VIII (recombinant) for routine prophylaxis in adults with hemophilia A
Healthcare company Baxter International (NYSE:BAX) revealed on Thursday the receipt of approval for its new reconstitution system for ADVATE (Antihemophilic Factor [Recombinant]) from the US Food and Drug Administration (FDA).
2) globulins or antihemophilic factor (2200 Blister)
M2 PHARMA-May 12, 2014-Bayer receives approval from US FDA for Kogenate FS antihemophilic factor VIII (recombinant) for routine prophylaxis in adults with hemophilia A
Science company Pfizer Inc (NYSE:PFE) stated on Monday the receipt of approval from the US Food and Drug Administration (FDA) for the use of a prefilled dual-chamber syringe for administration of XYNTHA Antihemophilic Factor (Recombinant) Plasma/Albumin-Free for haemophilia A, an inherited disease that prevents the blood from clotting properly.
ADVATE is the sole antihemophilic factor approved in the US for prophylactics of hemophilia A patients of all ages.

Full browser ?